Richards CA - Search Results

1

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase.

Huber BE, Austin EA, Richards CA, Davis ST, Good SS. Huber BE, et al. Among authors: richards ca. Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):8302-6. doi: 10.1073/pnas.91.17.8302. Proc Natl Acad Sci U S A. 1994. PMID: 8058798 Free PMC article.

2

Retroviral-mediated gene therapy for the treatment of hepatocellular carcinoma: an innovative approach for cancer therapy.

Huber BE, Richards CA, Krenitsky TA. Huber BE, et al. Among authors: richards ca. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8039-43. doi: 10.1073/pnas.88.18.8039. Proc Natl Acad Sci U S A. 1991. PMID: 1654555 Free PMC article.

3

Transcriptional regulatory sequences of carcinoembryonic antigen: identification and use with cytosine deaminase for tumor-specific gene therapy.

Richards CA, Austin EA, Huber BE. Richards CA, et al. Hum Gene Ther. 1995 Jul;6(7):881-93. doi: 10.1089/hum.1995.6.7-881. Hum Gene Ther. 1995. PMID: 7578407

4

Virus-directed enzyme/prodrug therapy (VDEPT). Selectively engineering drug sensitivity into tumors.

Huber BE, Richards CA, Austin EA. Huber BE, et al. Among authors: richards ca. Ann N Y Acad Sci. 1994 May 31;716:104-14; discussion 140-3. doi: 10.1111/j.1749-6632.1994.tb21706.x. Ann N Y Acad Sci. 1994. PMID: 8024189

5

In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.

Huber BE, Austin EA, Good SS, Knick VC, Tibbels S, Richards CA. Huber BE, et al. Among authors: richards ca. Cancer Res. 1993 Oct 1;53(19):4619-26. Cancer Res. 1993. PMID: 8402637

6

Alterations in tumor angiogenesis associated with stable expression of the HIV tat gene.

Huber BE, Richards CA, Martin JL, Wirth PJ. Huber BE, et al. Among authors: richards ca. Mol Carcinog. 1992;5(4):293-300. doi: 10.1002/mc.2940050410. Mol Carcinog. 1992. PMID: 1379815

7

Characterization of a transforming N-ras gene in the human hepatoma cell line Hep G2: additional evidence for the importance of c-myc and ras cooperation in hepatocarcinogenesis.

Richards CA, Short SA, Thorgeirsson SS, Huber BE. Richards CA, et al. Cancer Res. 1990 Mar 1;50(5):1521-7. Cancer Res. 1990. PMID: 2154325

8

The transcriptional control region of the human carcinoembryonic antigen gene: DNA sequence and homology studies.

Richards CA, Wolberg AS, Huber BE. Richards CA, et al. DNA Seq. 1993;4(3):185-96. doi: 10.3109/10425179309015631. DNA Seq. 1993. PMID: 8161821

9

Generation of a transgenic model for retrovirus-mediated gene therapy for hepatocellular carcinoma is thwarted by the lack of transgene expression.

Richards CA, Huber BE. Richards CA, et al. Hum Gene Ther. 1993 Apr;4(2):143-50. doi: 10.1089/hum.1993.4.2-143. Hum Gene Ther. 1993. PMID: 8388259

10

Regulated expression of artificial chimeric genes contained in retroviral vectors: implications for virus-directed enzyme prodrug therapy (VDEPT) and other gene therapy applications.

Huber BE, Richards CA. Huber BE, et al. Among authors: richards ca. J Drug Target. 1996;3(5):349-56. doi: 10.3109/10611869608996826. J Drug Target. 1996. PMID: 8866654

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters